Chrysos (ASX:C79) secured a AU$200 million, three-year syndicated refinancing with ANZ Group Holdings (NZE:ANZ, ASX:ANZ), National Australia Bank (ASX:NAB), and Export Finance Australia, replacing its previous asset-based structure with a more flexible corporate-style debt facility, according to a Thursday filing with the Australian bourse.

The new package includes term and revolving debt with an accordion feature, improved pricing and covenants, lower commitment fees, and about AU$105 million in additional headroom to refinance existing facilities and support growth, per the filing.

The structure is secured across multiple jurisdictions and incorporates standard corporate covenants, including net leverage and interest coverage ratios, the filing said.

The company said the refinancing boosts financial flexibility to accelerate PhotonAssay deployment and manufacturing, targeting a return to 18 units per year, backed by a forward order book of 22 units and 27 long-lead components, the filing added.

ANZ Group 's Kiwi shares were down nearly 1% in recent Thursday trade.